About
Apeiron Fund is a closed-end core buyout fund targeting a unique investment thesis. We acquire and rebrand Natura Cultivation facilities, Cookies brand dispensaries, and senior living portfolios into Avicenna Medical Centers, specializing in plant-based pharmaceuticals. This innovative approach addresses the polypharmacy pain point, offering a cost-effective solution with a $10 production cost yielding a 400% return. With a $1 billion fund size, a 10-year horizon, and a minimum investment of $20 million, we aim to achieve an 8% or higher cap rate. Our fee structure is investor-friendly, featuring 0% management fees, an 8% hurdle rate, a 2% catch-up, and a 20% carry. A 2% due diligence fee is required within 10 days of signing, available to qualified purchasers only.
Learn More